Developer docs
API playgroundTry for free, no card

Search company profiles

Cerebrum DAO

Full company profile

uuid000ae3y

Namestring
Cerebrum DAO
Legal namestring
Cerebrum DAO Association
Websiteurl
cerebrumdao.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Cerebrum DAO is a decentralized autonomous organization (DAO) founded in 2023 and headquartered in Zürich, Switzerland, that operates as a community-powered funding mechanism for translational neuroscience research, with an initial focus on preventing neurodegeneration and Alzheimer's disease. The organization enables community members to collectively identify, fund, and govern neuroscience projects through the NEURON governance token (86 billion total supply, 38.7 billion circulating) and IP-NFT (Intellectual Property Non-Fungible Token) tokenization using Molecule's protocol. As of available data, Cerebrum DAO has deployed approximately $1.3 million across 7 research projects, including Percepta ($400K brain health supplement), Fission Bio ($400K protein-protein interaction inhibitors), Project Transfidelity ($254K protein synthesis at University of Zurich), Arctic Therapeutics (€75K Alzheimer's therapeutics), SK Channels ($60K Chapman University), Acta Pharmaceuticals ($100K equity), and Xponetiq ($50K consumer brain health app).

The organization operates a community-led go-to-market model where token holders participate in governance via Snapshot voting across working groups (Translational Neuroscience, Product, Coordination & Operations, Community & Awareness). Its technology stack includes Ethereum L1 and Base L2 deployment, with NEURON tokens traded on Uniswap and Aerodrome, and project-level IP governance tokens (CLAW, MITY, FIDEL, GALE) representing fractional rights over specific research IP portfolios. Revenue mechanics are forward-looking and contingent: IP licensing proceeds from companies developing therapeutics based on funded research, equity exits from spun-out neuroscience startups, and token utility fees from NEURON holders' preferential access to IP token sales and brain health products. Notable strategic collaborations include exclusive licensing agreements with Chapman University (KCa2.2 ion channel modulators) and Nacuity Pharmaceuticals (NACA for Alzheimer's), plus research collaborations with Harvard Medical School, UCL, and the UT Dallas Center for Brain Health.

Short descriptiontext

Cerebrum DAO is a Zürich-based decentralized autonomous organization that uses the NEURON governance token and IP-NFT tokenization to community-fund translational neuroscience research focused on Alzheimer's and neurodegeneration, deploying capital across seven projects and partnerships with Harvard, UCL, and Chapman University.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersZurich, Switzerland
HQ citystring
Zurich
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
decentralized science funding, biotechnology research funding, intellectual property tokenization, neuroscience research DAO, brain health therapeutics
Industry4 codes
PRIMARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAD
Coordination & Contributor Management (tasks, bounties, roles)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYFSAPAHAC
Governance Frameworks & DAO Tooling (modules, templates, standards)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code2 codes
  • Finance Services6199
  • Investors, Nec6799
Product category
Decentralized Biotechnology Research Funding
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Token Sale Proceeds
TypeOne Time License
Description

Cerebrum DAO is funded by the sale of NEURON tokens to members of the public. Private sales raised initial operating capital from strategic partners. Public sales were hosted on BIO Launchpad (bio.xyz). The token is now available for secondary market trading.

cerebrumdao.com
2IP Licensing and Commercialization
TypeLicensing Royalties
Description

IP from funded projects is tokenized using IPNFT protocol. Licensed to companies interested in developing new therapeutics, with proceeds distributed between researchers and the DAO. The DAO may also spin out discoveries into new neuroscience startups.

cerebrumdao.com
3Token Utility Revenue
TypeSubscription Recurring
Description

NEURON token holders receive exclusive early access to IP token sales for IP-NFT projects, discounted access to brain health products, and prioritized access to therapeutics as they come to market from the IP portfolio.

cerebrumdao.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1NEURON token initial circulating supply post-public sale
ModelOtherBilling cadencePay-as-you-go
Notes

Total supply: 86,000,000,000 NEURON. Circulating supply after initial public sale: 38,700,000,000 (45% of total supply). Token available on Uniswap (Ethereum) and Aerodrome (Base).

cerebrumdao.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Cerebrum DAO is a community-governed decentralized autonomous organization that funds translational neuroscience research to prevent neurodegeneration, with an initial focus on Alzheimer's disease. It raises capital through the NEURON governance token and deploys funds into research projects via IP-NFT tokenization, equity investments, and product development, while distributing IP license and governance rights back to its community of token holders. Funded projects include brain health supplements, therapeutic drug programs, and neuroscience-based mobile applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 6.7 million Americans currently living with Alzheimer's disease
+4 more records
Product and service4 records
1NEURON Token
CategoryGovernance token
Description

Governance and utility token of Cerebrum DAO with 86 billion total supply; provides voting power for DAO proposals, exclusive early access to IP token sales, discounted access to brain health products, and prioritized access to therapeutics developed from the IP portfolio. Available for trading on Uniswap (Ethereum) and Aerodrome (Base).

2Percepta
CategoryBrain health dietary supplement
Description

Patent-protected brain health natural dietary supplement with active ingredients PTI-00703 Cat's claw and MemorTea oolong tea extract; backed by a $400,000 Cerebrum DAO IP Portfolio License investment.

3Xponetiq App
CategoryConsumer mobile application
Description

Neuroscience-based mobile application for building brain-healthy habits through daily quests; developed by 21 Impact Labs using licensed neuroscience from the UT Dallas Center for Brain Health.

4CLAW Token (NEURON-Percepta IPT)
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeTechnology or Integration
Description

Molecule provides the IP-NFT (Intellectual Property Non-Fungible Token) protocol that Cerebrum DAO uses to tokenize research IP. This enables equitable distribution of license and governance rights to the community. The partnership allows for the creation of IP tokens (IPTs) representing fractional governance rights over intellectual property portfolios.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cerebrum DAO has co-funded projects with VitaDAO, including Fission Bio. VitaDAO is a decentralized biotech DAO focused on longevity research. The partnership enables joint funding of neuroscience projects and knowledge sharing within the DeSci ecosystem.

Strategic tierCoreTypeGTM or Marketing Partner
Description

BIO Protocol is a decentralized science (DeSci) platform built on Ethereum that enables community-driven funding and governance of biotechnology research. Cerebrum DAO is part of the BioDAO ecosystem under BIO Protocol. BIO Launchpad hosted the NEURON token public sale.

Strategic tierMinorTypeGTM or Marketing Partner
Description

DeSci Collective is a podcast and community platform for decentralized science. Listed as a partner supporting progress in brain health.

Strategic tierMinorTypeOthers
Description

What.digital provides digital marketing services and support for Cerebrum DAO communications and brand initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Senior researchers from Harvard Medical School and Mass General collaborate with Arctic Therapeutics (a Cerebrum DAO-funded project) on AT-001 development for Alzheimer's treatment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University College London researchers collaborate with Arctic Therapeutics on neurodegenerative disease research, providing scientific expertise and research capabilities.

8Harvard Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborating institution on Neuron-Gale galectin-3 inhibitor project, providing research expertise in neuroinflammation and Alzheimer's disease.

cerebrumdao.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Xponetiq app is based on licensed neuroscience from UT Dallas Center for Brain Health, enabling the app to help users build brain-healthy habits through daily quests.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Exclusive licensing agreement for NACA (N-acetylcysteine amide) development in neurological disorders, key to Arctic Therapeutics' AT-001 Alzheimer's treatment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

VitaDAO is a decentralized autonomous organization funding longevity research through community governance and IP-NFT tokenization — the same DeSci model Cerebrum DAO uses, making it the most direct peer in structure and mission (lonvity vs. brain health).

TypeBroad incumbent
Description

Molecule developed the IP-NFT protocol that Cerebrum DAO uses and operates a broader platform for tokenizing biotech IP across multiple DAOs; it is both a core technology partner and a broader incumbent in the DeSci IP-tokenization category.

TypeBroad incumbent
Description

BIO Protocol is the parent DeSci ecosystem and launchpad that hosted Cerebrum DAO's NEURON public sale. It is a broader incumbent coordinating many BioDAOs across different therapeutic areas.

TypeDirect peer
Description

AthenaDAO is a DeSci DAO funding women's health research through token-based governance and IP tokenization — directly comparable in structure (community-funded biotech DAO) but focused on a different therapeutic vertical.

TypeDirect peer
Description

HairDAO is a DeSci DAO focused on hair-loss research using the same community-governance and IP-NFT framework as Cerebrum DAO, but in a smaller, consumer-adjacent therapeutic vertical.

6PsyDAO
TypeDirect peer
Description

PsyDAO is a DeSci DAO funding psychedelic and mental health research with token-based governance, comparable to Cerebrum DAO in governance model and IP-tokenization approach, with overlapping brain-health themes.

TypeEmerging player
Description

LabDAO is a decentralized science DAO focused on enabling shared lab infrastructure and computational biology tools for DeSci communities, providing adjacent infrastructure rather than directly funding therapeutics like Cerebrum DAO.

TypeEmerging player
Description

ResearchHub is a decentralized scientific research platform that incentivizes scientists to share and review research, sharing the community-driven research ethos with Cerebrum DAO but without a treasury/IP-tokenization model.

9Pump Science
TypeEmerging player
Description

Pump Science is a DeSci launchpad and longevity-supplements protocol on Solana that funds and commercializes scientific compounds — a more consumer/longevity-focused analogue to Cerebrum DAO's supplement IP-NFT (Percepta/CLAW).

10GenomesDAO
TypeDirect peer
Description

GenomesDAO is a DeSci DAO enabling individuals to monetize genomic data for research, using token-based governance and IP tokenization comparable to Cerebrum DAO's community-owned research-funding model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cerebrum DAO

Decentralized Biotechnology Research Fundingcerebrumdao.com

Cerebrum DAO is a Zürich-based decentralized autonomous organization that uses the NEURON governance token and IP-NFT tokenization to community-fund translational neuroscience research focused on Alzheimer's and neurodegeneration, deploying capital across seven projects and partnerships with Harvard, UCL, and Chapman University.

What Cerebrum DAO does

Cerebrum DAO is a decentralized autonomous organization (DAO) founded in 2023 and headquartered in Zürich, Switzerland, that operates as a community-powered funding mechanism for translational neuroscience research, with an initial focus on preventing neurodegeneration and Alzheimer's disease. The organization enables community members to collectively identify, fund, and govern neuroscience projects through the NEURON governance token (86 billion total supply, 38.7 billion circulating) and IP-NFT (Intellectual Property Non-Fungible Token) tokenization using Molecule's protocol. As of available data, Cerebrum DAO has deployed approximately $1.3 million across 7 research projects, including Percepta ($400K brain health supplement), Fission Bio ($400K protein-protein interaction inhibitors), Project Transfidelity ($254K protein synthesis at University of Zurich), Arctic Therapeutics (€75K Alzheimer's therapeutics), SK Channels ($60K Chapman University), Acta Pharmaceuticals ($100K equity), and Xponetiq ($50K consumer brain health app).

The organization operates a community-led go-to-market model where token holders participate in governance via Snapshot voting across working groups (Translational Neuroscience, Product, Coordination & Operations, Community & Awareness). Its technology stack includes Ethereum L1 and Base L2 deployment, with NEURON tokens traded on Uniswap and Aerodrome, and project-level IP governance tokens (CLAW, MITY, FIDEL, GALE) representing fractional rights over specific research IP portfolios. Revenue mechanics are forward-looking and contingent: IP licensing proceeds from companies developing therapeutics based on funded research, equity exits from spun-out neuroscience startups, and token utility fees from NEURON holders' preferential access to IP token sales and brain health products. Notable strategic collaborations include exclusive licensing agreements with Chapman University (KCa2.2 ion channel modulators) and Nacuity Pharmaceuticals (NACA for Alzheimer's), plus research collaborations with Harvard Medical School, UCL, and the UT Dallas Center for Brain Health.

Cerebrum DAO firmographics

Firmographics
Name
Cerebrum DAO
Legal name
Cerebrum DAO Association
Website
https://cerebrumdao.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
Cerebrum DAO is a Zürich-based decentralized autonomous organization that uses the NEURON governance token and IP-NFT tokenization to community-fund translational neuroscience research focused on Alzheimer's and neurodegeneration, deploying capital across seven projects and partnerships with Harvard, UCL, and Chapman University.
Ownership category
akta.pro rank

Cerebrum DAO industry classification

Industry
Product category
Decentralized Biotechnology Research Funding
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Finance Services (6199), Investors, Nec (6799)
akta.pro industry
PRIMARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAD
Coordination & Contributor Management (tasks, bounties, roles)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYFSAPAHAC
Governance Frameworks & DAO Tooling (modules, templates, standards)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)

Keywords

  • Decentralized science funding
  • Biotechnology research funding
  • Intellectual property tokenization
  • Neuroscience research DAO
  • Brain health therapeutics

Where Cerebrum DAO is headquartered

Location

Headquarters

HQ city
Zurich
HQ country
Switzerland
HQ region
Europe

Markets served

Cerebrum DAO business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Token Sale Proceeds: Cerebrum DAO is funded by the sale of NEURON tokens to members of the public. Private sales raised initial operating capital from strategic partners. Public sales were hosted on BIO Launchpad (bio.xyz). The token is now available for secondary market trading.
  2. IP Licensing and Commercialization: IP from funded projects is tokenized using IPNFT protocol. Licensed to companies interested in developing new therapeutics, with proceeds distributed between researchers and the DAO. The DAO may also spin out discoveries into new neuroscience startups.
  3. Token Utility Revenue: NEURON token holders receive exclusive early access to IP token sales for IP-NFT projects, discounted access to brain health products, and prioritized access to therapeutics as they come to market from the IP portfolio.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goNEURON token initial circulating supply post-public sale

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Cerebrum DAO product offering

Product offering

Core offering

Cerebrum DAO is a community-governed decentralized autonomous organization that funds translational neuroscience research to prevent neurodegeneration, with an initial focus on Alzheimer's disease. It raises capital through the NEURON governance token and deploys funds into research projects via IP-NFT tokenization, equity investments, and product development, while distributing IP license and governance rights back to its community of token holders. Funded projects include brain health supplements, therapeutic drug programs, and neuroscience-based mobile applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • NEURON Token Governance and utility token of Cerebrum DAO with 86 billion total supply; provides voting power for DAO proposals, exclusive early access to IP token sales, discounted access to brain health products, and prioritized access to therapeutics developed from the IP portfolio. Available for trading on Uniswap (Ethereum) and Aerodrome (Base).
  • Percepta Patent-protected brain health natural dietary supplement with active ingredients PTI-00703 Cat's claw and MemorTea oolong tea extract; backed by a $400,000 Cerebrum DAO IP Portfolio License investment.
  • Xponetiq App Neuroscience-based mobile application for building brain-healthy habits through daily quests; developed by 21 Impact Labs using licensed neuroscience from the UT Dallas Center for Brain Health.
  • CLAW Token (NEURON-Percepta IPT)

Quantifiable outcome

  • 6.7 million Americans currently living with Alzheimer's disease
  • +4 more outcomes

Companies that use Cerebrum DAO

Customer profile

Segments3 records

Ideal customer profiles3 records

Cerebrum DAO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Cerebrum DAO partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Molecule AGcoreTechnology or IntegrationMolecule provides the IP-NFT (Intellectual Property Non-Fungible Token) protocol that Cerebrum DAO uses to tokenize research IP. This enables equitable distribution of license and governance rights to the community. The partnership allows for the creation of IP tokens (IPTs) representing fractional governance rights over intellectual property portfolios.
  • VitaDAOcoreStrategic or Co-development PartnerCerebrum DAO has co-funded projects with VitaDAO, including Fission Bio. VitaDAO is a decentralized biotech DAO focused on longevity research. The partnership enables joint funding of neuroscience projects and knowledge sharing within the DeSci ecosystem.
  • BIO ProtocolcoreGTM or Marketing PartnerBIO Protocol is a decentralized science (DeSci) platform built on Ethereum that enables community-driven funding and governance of biotechnology research. Cerebrum DAO is part of the BioDAO ecosystem under BIO Protocol. BIO Launchpad hosted the NEURON token public sale.
  • DeSci CollectiveminorGTM or Marketing PartnerDeSci Collective is a podcast and community platform for decentralized science. Listed as a partner supporting progress in brain health.
  • What.digitalminorOthersWhat.digital provides digital marketing services and support for Cerebrum DAO communications and brand initiatives.
  • Harvard ResearcherscoreStrategic or Co-development PartnerSenior researchers from Harvard Medical School and Mass General collaborate with Arctic Therapeutics (a Cerebrum DAO-funded project) on AT-001 development for Alzheimer's treatment.
  • UCL ResearcherscoreStrategic or Co-development PartnerUniversity College London researchers collaborate with Arctic Therapeutics on neurodegenerative disease research, providing scientific expertise and research capabilities.
  • Harvard Medical SchoolcoreStrategic or Co-development PartnerCollaborating institution on Neuron-Gale galectin-3 inhibitor project, providing research expertise in neuroinflammation and Alzheimer's disease.
  • University of Texas at Dallas Center for Brain HealthcoreStrategic or Co-development PartnerXponetiq app is based on licensed neuroscience from UT Dallas Center for Brain Health, enabling the app to help users build brain-healthy habits through daily quests.
  • Nacuity PharmaceuticalscoreOEM/ Whitelabel/ Licensing PartnerExclusive licensing agreement for NACA (N-acetylcysteine amide) development in neurological disorders, key to Arctic Therapeutics' AT-001 Alzheimer's treatment.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Cerebrum DAO competitors and assessment

Company assessment

Direct peers

  • VitaDAO: VitaDAO is a decentralized autonomous organization funding longevity research through community governance and IP-NFT tokenization — the same DeSci model Cerebrum DAO uses, making it the most direct peer in structure and mission (lonvity vs. brain health).
  • AthenaDAO: AthenaDAO is a DeSci DAO funding women's health research through token-based governance and IP tokenization — directly comparable in structure (community-funded biotech DAO) but focused on a different therapeutic vertical.
  • HairDAO: HairDAO is a DeSci DAO focused on hair-loss research using the same community-governance and IP-NFT framework as Cerebrum DAO, but in a smaller, consumer-adjacent therapeutic vertical.
  • PsyDAO: PsyDAO is a DeSci DAO funding psychedelic and mental health research with token-based governance, comparable to Cerebrum DAO in governance model and IP-tokenization approach, with overlapping brain-health themes.
  • GenomesDAO: GenomesDAO is a DeSci DAO enabling individuals to monetize genomic data for research, using token-based governance and IP tokenization comparable to Cerebrum DAO's community-owned research-funding model.

Broad incumbents

  • Molecule (Molecule AG): Molecule developed the IP-NFT protocol that Cerebrum DAO uses and operates a broader platform for tokenizing biotech IP across multiple DAOs; it is both a core technology partner and a broader incumbent in the DeSci IP-tokenization category.
  • BIO Protocol: BIO Protocol is the parent DeSci ecosystem and launchpad that hosted Cerebrum DAO's NEURON public sale. It is a broader incumbent coordinating many BioDAOs across different therapeutic areas.

Emerging players

  • LabDAO: LabDAO is a decentralized science DAO focused on enabling shared lab infrastructure and computational biology tools for DeSci communities, providing adjacent infrastructure rather than directly funding therapeutics like Cerebrum DAO.
  • ResearchHub: ResearchHub is a decentralized scientific research platform that incentivizes scientists to share and review research, sharing the community-driven research ethos with Cerebrum DAO but without a treasury/IP-tokenization model.
  • Pump Science: Pump Science is a DeSci launchpad and longevity-supplements protocol on Solana that funds and commercializes scientific compounds — a more consumer/longevity-focused analogue to Cerebrum DAO's supplement IP-NFT (Percepta/CLAW).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Cerebrum DAO social profiles

Digital presence

Cerebrum DAO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cerebrum DAO leadership team

Management profile

Number of profiles

Profiles7 records

Cerebrum DAO funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cerebrum DAO M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cerebrum DAO

What does Cerebrum DAO do?

Cerebrum DAO is a community-governed decentralized autonomous organization that funds translational neuroscience research to prevent neurodegeneration, with an initial focus on Alzheimer's disease. It raises capital through the NEURON governance token and deploys funds into research projects via IP-NFT tokenization, equity investments, and product development, while distributing IP license and governance rights back to its community of token holders. Funded projects include brain health supplements, therapeutic drug programs, and neuroscience-based mobile applications.

Is Cerebrum DAO a public or private company?

Cerebrum DAO is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Cerebrum DAO founded?

Cerebrum DAO was founded in 2023. It employs 1 to 10 people.

Where is Cerebrum DAO based?

Cerebrum DAO is headquartered in Zurich, Switzerland, in the Europe region.

How does Cerebrum DAO make money?

Three revenue lines are on record. Token Sale Proceeds are the primary driver. The others are IP Licensing and Commercialization and token Utility Revenue.

Who are Cerebrum DAO's main competitors?

Direct peers on record are VitaDAO, AthenaDAO, HairDAO, PsyDAO and GenomesDAO. Broad incumbents are Molecule (Molecule AG) and BIO Protocol. Emerging players are LabDAO, ResearchHub and Pump Science.

Does Cerebrum DAO have an API?

No public API is recorded for Cerebrum DAO.

What industry is Cerebrum DAO in?

Cerebrum DAO's product category is Decentralized Biotechnology Research Funding. Its primary akta.pro industry code is FSAPAHAE, Grants, Funding & Budget Allocation Platforms, with a secondary code of FSAPAHAD, Coordination & Contributor Management (tasks, bounties, roles). Its NAICS code is 541714 and its SIC code is 6199.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals